In the health sector, Elevance Health has predicted a profit dip for 2026, citing high medical costs driven by increased demand for specialized healthcare. Roche's new obesity drug shows promise, achieving significant weight loss in clinical trials. The drug aims to compete with established rivals like Lilly and Novo, signaling competitive advancements in obesity treatments. Concerns over the Nipah virus have accelerated public health responses across Asia, with heightened airport screenings following confirmed cases in India. The virus poses severe health threats, lacking a known cure and with a significant fatality rate.